CEO at CDMO Protium Science
PS
Protium Science - CDMO
The startup develops biopharmaceuticals by creating production cell lines and formulating drug substances and finished drugs tailored to patient needs. This approach enables the delivery of personalized medicines, addressing the lack of access to customized treatment options for patients.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$11MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biopharmaceuticals by creating production cell lines and formulating drug substances and finished drugs tailored to patient needs. This approach enables the delivery of personalized medicines, addressing the lack of access to customized treatment options for patients.